Anti-TNF therapy

October 14, 2019October 11, 2019

Understanding the Cancer Risks Associated with IBD Medications

Columns, Finding the Silver Linings - a column by Lisa Burks

A topic that has arisen lately in the Crohn’s and ulcerative colitis community is the risk of some types of cancers due to the medications that we take. Most medications ... Read more

May 2, 2018May 2, 2018

Anti-TNF Therapy Linked to Higher Survival in Crohn’s Patients, Study Reports

News

Anti-TNF therapy is associated with lower mortality rates compared to prolonged corticosteroid use in patients with Crohn’s disease, researchers suggest. This reduced mortality may be linked to lower rates of ... Read more

March 28, 2016March 28, 2016

Phase 3 Trial Results of Stelara for Crohn’s Disease Indicate Promising Results

News

Janssen Pharmaceuticals’ drug candidate Stelara (ustekinumab) demonstrated positive therapeutic effects in a recent Phase 3 clinical trial, inducing clinical response and remission in adult patients with moderate to severe Crohn’s ... Read more

March 7, 2016March 7, 2016

IBD Patients with Prior Cancer May Run ‘Mild Risk’ of Recurrence with Use of Anti-TNF Therapy

IBD News, News

Research into the risk of new cancers in inflammatory bowel disease (IBD) patients treated for a prior malignancy and undergoing anti-tumor necrosis factor (anti-TNF) therapy supported the treatment’s use, but found a slight risk ... Read more